Overview

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

Status:
Active, not recruiting

Trial end date:
2022-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determined the best scheme in paclitaxel and cisplatin，paclitaxel and fluorouracil，paclitaxel and carboplatin concurrent with radiotherapy for patients with local advanced esophageal Squamous Cell Carcinoma.

Phase:

Phase 3

Details

Lead Sponsor:

Fudan University

Collaborators:

Fudan University Shanghai Cancer Center Minhang Branch
Gansu Cancer Hospital
Huadong Hospital
Jiangsu Cancer Institute & Hospital
Jiangxi Provincial Cancer Hospital
Shanxi Province Cancer Hospital
The First Affiliated Hospital of Xiamen University
Wuxi No. 4 People's Hospital

Treatments:

Albumin-Bound Paclitaxel
Carboplatin
Cisplatin
Fluorouracil
Paclitaxel